Throat Fullness: Labs, Diagnosis, and Next Steps

What Throat Fullness Actually Means in Clinical Terms

Globus pharyngeus is the persistent or intermittent sensation of a lump, tightness, or fullness in the throat that occurs without a true structural obstruction. The Rome IV criteria define it as a functional esophageal disorder when organic causes have been excluded [1]. It is not the same as dysphagia. Patients with globus can swallow food and liquids normally, and the sensation often improves during meals rather than worsening.

A 2012 systematic review published in Clinical Otolaryngology estimated that globus accounts for approximately 4% of all new ENT referrals, with a lifetime prevalence reaching 45% in some population surveys [2]. Women report the symptom slightly more often than men, and onset peaks between ages 40 and 60. The sensation can be constant or come and go across weeks. Stress, fatigue, and postnasal drip commonly make it worse.

"Globus is one of the most common complaints we see in a head-and-neck practice, yet it remains a diagnosis of exclusion," noted Dr. Peter Belafsky, Professor of Otolaryngology at UC Davis, in a 2020 review of oropharyngeal diagnostics [3]. That means the clinical goal is not to confirm globus itself but to rule out conditions that mimic it.

Why You Feel Throat Fullness: The Major Causes

Acid reflux, specifically laryngopharyngeal reflux (LPR), is the single most cited association. A meta-analysis in the American Journal of Gastroenterology found objective evidence of GERD or LPR in 23% to 68% of globus patients depending on the diagnostic method used [4]. LPR differs from typical heartburn. Stomach acid reaches the larynx and pharynx, causing mucosal irritation without the classic burning sensation in the chest. Posterior laryngeal edema, erythema of the arytenoids, and cobblestoning of the pharyngeal wall are all signs your ENT may document during laryngoscopy.

Thyroid pathology is another consideration. Palpable thyroid nodules exist in roughly 5% of women and 1% of men on physical exam, but high-resolution ultrasound detects nodules in up to 68% of adults screened [5]. Most are benign. A 2019 Thyroid journal study found that only 7 to 15% of thyroid nodules sampled by fine-needle aspiration (FNA) are malignant [6]. Still, a nodule pressing on the trachea or esophagus can generate a legitimate fullness sensation. Goiter from autoimmune thyroiditis (Hashimoto's) is another thyroid-related cause that lab work can identify early.

Other causes include:

• Cricopharyngeal muscle dysfunction. Hypertonic or spasmodic upper esophageal sphincter tone can create a squeezing sensation at the level of the cricoid cartilage.
• Esophageal motility disorders. Conditions like esophageal spasm or achalasia occasionally present with globus as an early symptom before true dysphagia develops.
• Allergic or eosinophilic esophagitis (EoE). EoE affects approximately 1 in 2,000 adults in the U.S. and can produce throat fullness, food impaction, and chest discomfort [7].
• Cervical spine osteophytes. Large anterior osteophytes at C3 through C6 can mechanically compress the posterior pharynx.
• Anxiety and somatization. A prospective study in Psychosomatics reported that 96% of globus patients met criteria for at least one psychiatric diagnosis, most commonly generalized anxiety disorder [8].

The Lab Workup Your Doctor Should Order

The right blood tests depend on the clinical picture, but a reasonable baseline panel for unexplained throat fullness includes four categories of labs.

Thyroid function. TSH is the first-line screening test. If TSH is abnormal, free T4 and free T3 refine the diagnosis. Anti-thyroid peroxidase (anti-TPO) antibodies help identify Hashimoto's thyroiditis, the most common cause of hypothyroidism in iodine-sufficient populations [9]. The American Thyroid Association recommends thyroid ultrasound for any patient with a palpable nodule or abnormal thyroid function tests [10].

Complete blood count (CBC) with differential. An elevated white blood cell count may point toward infection or inflammation. Eosinophilia (eosinophils above 500 cells/mcL) raises the possibility of EoE or an allergic process.

Inflammatory markers. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are nonspecific but help screen for systemic inflammatory conditions, including rare entities like thyroiditis or retropharyngeal abscess.

Iron studies and B12. The Plummer-Vinson syndrome triad of dysphagia, iron-deficiency anemia, and esophageal webs is uncommon in developed countries but still worth excluding. A ferritin level below 30 ng/mL in the setting of globus symptoms warrants further investigation [11].

If these baseline labs return normal, the next step is not more blood work. It is direct visualization.

Imaging and Procedures: What Comes After Labs

Flexible nasopharyngolaryngoscopy (NPL) is the most important single test for throat fullness. Performed in the ENT office with topical anesthesia, it gives a real-time view of the nasopharynx, oropharynx, hypopharynx, and larynx. The clinician can assess for masses, mucosal lesions, pooling of secretions, vocal cord paralysis, and signs of LPR such as posterior commissure hypertrophy.

A 2017 Laryngoscope study of 699 patients presenting with globus found that NPL identified a structural abnormality in 8.3% of cases [12]. That number is low, but the test's real value lies in ruling out malignancy and providing reassurance. The 2022 British Association of Otorhinolaryngology (ENT-UK) guidelines recommend NPL as the initial investigation for all patients with persistent globus lasting more than 4 weeks [13].

Barium swallow. This fluoroscopic study evaluates esophageal motility in real time and can detect webs, strictures, Zenker's diverticulum, and extrinsic compression from osteophytes or thyroid masses. It is particularly useful when dysphagia coexists with globus or when the patient describes a sensation localized to the mid or lower esophagus.

Upper endoscopy (EGD). Esophagogastroduodenoscopy is indicated when GERD or EoE is suspected. For EoE specifically, the ACG 2020 clinical guideline recommends taking at least six biopsies from the proximal and distal esophagus, because endoscopic appearance alone misses up to 10% of cases [14]. A threshold of 15 or more eosinophils per high-power field on biopsy confirms the diagnosis.

Esophageal manometry. High-resolution manometry (HRM) maps pressure along the entire esophagus and is the gold standard for diagnosing motility disorders. The Chicago Classification v4.0 system categorizes findings into disorders of EGJ outflow obstruction (including achalasia), major peristaltic disorders, and minor peristaltic disorders [15]. Manometry is typically reserved for cases where reflux treatment fails and a motility disorder is suspected.

Thyroid ultrasound. If TSH is abnormal or palpation reveals a nodule or asymmetry, ultrasound is the next step. The ACR Thyroid Imaging Reporting and Data System (TI-RADS) assigns a risk score to each nodule, guiding FNA decisions [16].

The GERD and LPR Connection: When Acid Is the Culprit

Laryngopharyngeal reflux deserves its own section because it is the most frequently treated cause of throat fullness, yet also the most overdiagnosed. The Reflux Symptom Index (RSI) and Reflux Finding Score (RFS) are widely used clinical tools, but both have poor specificity. A 2010 study in The Laryngoscope found that healthy controls without reflux had a mean RFS of 5.2, while the commonly used cutoff for "positive" LPR is 7 [17].

This means many patients receive empiric proton pump inhibitor (PPI) therapy for suspected LPR without objective confirmation. The American Gastroenterological Association's 2020 clinical practice update recommends limiting empiric PPI trials to 8 to 12 weeks at standard dose (omeprazole 20 mg twice daily or equivalent) and discontinuing if no improvement occurs [18].

"Reflux is a real cause of throat symptoms, but not every throat symptom is reflux," stated Dr. Craig Zalvan, Chief of Otolaryngology at Phelps Hospital, in a frequently cited 2017 JAMA Otolaryngology paper that compared PPI therapy to a Mediterranean diet with alkaline water for LPR symptoms [19]. That trial found the dietary approach was at least as effective as PPIs, with RSI improvements of 39.8% in the diet group versus 27.2% in the PPI group.

For patients who do not respond to an empiric PPI trial, ambulatory pH monitoring (either wireless Bravo capsule or impedance-pH catheter) provides objective reflux data and should be performed before escalating to surgical options like fundoplication.

Anxiety, Stress, and the Brain-Throat Axis

The relationship between psychological distress and globus is bidirectional. Chronic throat fullness generates health anxiety, and pre-existing anxiety disorders lower the sensory threshold for detecting normal pharyngeal sensations.

A 2018 prospective cohort study in Clinical Otolaryngology followed 89 patients with globus for 12 months. Patients who scored above the median on the Hospital Anxiety and Depression Scale (HADS) at baseline were 2.8 times more likely to have persistent symptoms at one year compared to those with lower scores (95% CI 1.3 to 6.1) [20]. This association held even after adjusting for reflux status.

Cognitive behavioral therapy (CBT) has limited but promising evidence in globus management. A pilot randomized controlled trial published in Clinical Otolaryngology in 2016 assigned 30 globus patients to either CBT or standard care. The CBT group showed a statistically significant reduction in symptom severity at 6 months (p = 0.03), though the sample size limits generalizability [21].

SSRIs and low-dose tricyclic antidepressants (TCAs) are sometimes prescribed off-label. Amitriptyline at 10 to 25 mg nightly is the most commonly used TCA for functional esophageal disorders, based on extrapolation from IBS and functional dyspepsia data rather than globus-specific trials [22].

When to Worry: Red Flags That Change the Workup

Most throat fullness is benign. But certain features shift the differential toward malignancy, infection, or progressive neurological disease and require accelerated workup.

True dysphagia (difficulty swallowing solids or liquids, not just a sensation) warrants urgent EGD or barium swallow. Odynophagia (pain with swallowing) suggests mucosal ulceration, infection, or malignancy. Unintentional weight loss of 5% or more over 6 to 12 months is an independent red flag. Hoarseness lasting more than 3 weeks requires laryngoscopy to evaluate the vocal cords, per NICE guideline NG12 for suspected cancer referral [23].

A palpable neck mass, progressive symptoms despite treatment, or a history of head-and-neck radiation all lower the threshold for cross-sectional imaging with CT or MRI. Patients over age 50 with new-onset globus and any one of these red flags should be seen by ENT within 2 weeks.

Building Your Action Plan: Next Steps by Scenario

The right next move depends on where you are in the diagnostic sequence.

If you have not seen a doctor yet: Start with your primary care physician. Request a thyroid exam, basic labs (TSH, CBC, CRP, ferritin), and a referral to ENT if the sensation has persisted for more than 4 weeks. Document when the fullness started, what makes it better or worse, and whether you have heartburn, regurgitation, voice changes, or difficulty swallowing.

If labs and laryngoscopy are normal: An 8 to 12 week trial of a PPI (omeprazole 20 mg twice daily or lansoprazole 30 mg daily) is reasonable. Raise the head of your bed 6 inches. Avoid eating within 3 hours of lying down.

If the PPI trial fails: Return to your gastroenterologist for pH impedance testing or EGD with biopsies. Manometry should be considered if the EGD is unremarkable.

If anxiety or stress is a major contributor: A structured course of CBT (typically 8 to 12 sessions) is the best-studied behavioral intervention. Discuss low-dose amitriptyline (10 to 25 mg at bedtime) or an SSRI with your prescriber if functional symptoms are refractory.

If a thyroid nodule is found: Follow ACR TI-RADS scoring. TI-RADS 3 nodules 2.5 cm or larger, TI-RADS 4 nodules 1.5 cm or larger, and all TI-RADS 5 nodules 1 cm or larger should undergo FNA [16].

Schedule follow-up within 4 to 6 weeks of starting any new treatment to reassess symptom trajectory and adjust the plan.